跳至主要内容
临床试验/NCT02877758
NCT02877758Unknown1 期

Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging - A Randomized Controlled Double Blind Study

Tomorrowlabs GmbH0 个研究点目标入组 40 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
1 期
入组人数
40
主要终点
Validated Assessment Scales for Age-related Changes of the Face

研究概览

简要总结

Tomorrowlabs has developed a revolutionary cosmeceutical formulation to rejuvenate aging skin. Tomorrowlabs is conducting this research to study whether this cosmeceutical can reduce the visible signs of cutaneous aging.

详细描述

It is proposed to study a cosmeceutical formulation designed to reduce the visible signs of cutaneous aging. It is expected that daily application of the formulation may minimize wrinkles and fine lines of the face.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteers who desire to improve their appearance by reducing the visible signs of cutaneous aging in the face

排除标准

  • Subjects who have undergone facial plastic surgery or aesthetic dermatology treatments to the face (such as fillers and neuromodulators) in the past 6 months
  • Subjects with a history of collagen vascular disease, cutis laxa, connective tissue disease, psoriasis, or lupus.
  • Subjects diagnosed with scleroderma.
  • Subjects with a body mass index (BMI) >
  • Subjects taking steroid therapy.

结局指标

主要结局

Validated Assessment Scales for Age-related Changes of the Face

时间窗: 3 months

A reliable tool for valid and reproducible assessment of the aging process in various face areas will be employed by our independent panel of assessors to scale the primary outcome. (1-3)

次要结局

  • Subject Satisfaction With the Results(3 months)
  • Skin quality assessment(3 months)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Investigation of a Novel Cosmeceutical to Reduce the... | 临床试验